bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodules Transcript
Source: SeekingAlpha
2026-06-17 00:12:09 ET
bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodules June 16, 2026 7:00 PM EDT...
Read the full article on Seeking Alpha
For further details see:
bioAffinity Technologies, Inc. (BIAF) Discusses Noninvasive Testing and Risk Stratification for Indeterminate Lung Nodules Transcript
bioAffinity Technologies Inc.
NASDAQ: BIAF
BIAF Trading
-16.47% G/L:
$7.86 Last:
761,793 Volume:
$9.96 Open:
BIAF Latest News
September 01, 2026 08:00:00 am
bioAffinity Technologies Advances CyPath® Lung for Surveillance of Lung Cancer Survivors
July 22, 2026 08:08:00 am
bioAffinity Technologies and Pictor®, Inc. Partner to Develop and Commercialize bioAffinity's Diagnostics for Asthma and COPD
$4,543,696
4,349,802
N/A
3
N/A
Medical Diagnostics & Screening
Healthcare
US
San Antonio
